Moore Paul Andrew
SEC CIK 1938192 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZYME | Zymeworks Inc. | CSO | 58.1K | — | $1.14M | 8 | 2024-01-05 | 2026-01-12 |
Most active insiders at ZYME, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Galbraith Kenneth | COB, CEO, Dir | — | $3.34M |
| 2 | Moore Paul Andrew | CSO | — | $721.5K |
| 3 | Smith Jeffrey T L | EVP, Chief Medical Off | — | $475.6K |
| 4 | Hollywood Mark | EVP, COO | — | $138.7K |
| 5 | PATTERSON LEONE D | EVP, Chief Bus, Fin Off | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-12 | 2026-01-12 | ZYME | Zymeworks Inc. | Moore Paul Andrew | CSO | M - OptEx | $0.00 | +17.7K | 58.1K | +44% | $0 |
| D | 2026-01-12 | 2026-01-12 | ZYME | Zymeworks Inc. | Moore Paul Andrew | CSO | S - Sale+OE | $22.67 | -9,560 | 48.5K | -16% | -$216.7K |
| DM | 2026-01-05 | 2026-01-05 | ZYME | Zymeworks Inc. | Moore Paul Andrew | CSO | S - Sale+OE | $25.10 | -20.1K | 31.2K | -39% | -$504.8K |
| DM | 2026-01-05 | 2026-01-05 | ZYME | Zymeworks Inc. | Moore Paul Andrew | CSO | M - OptEx | $0.00 | +37.2K | 51.2K | +265% | $0 |
| DM | 2025-01-06 | 2025-01-06 | ZYME | Zymeworks Inc. | Moore Paul Andrew | CSO | M - OptEx | $0.00 | +37.2K | 24.5K | New | $0 |
| DM | 2025-01-06 | 2025-01-06 | ZYME | Zymeworks Inc. | Moore Paul Andrew | CSO | S - Sale+OE | $14.92 | -21.2K | 14.7K | -59% | -$316.3K |
| DM | 2024-01-08 | 2024-01-05+ | ZYME | Zymeworks Inc. | Moore Paul Andrew | CSO | S - Sale+OE | $10.79 | -9,799 | 9,706 | -50% | -$105.7K |
| D | 2024-01-08 | 2024-01-05 | ZYME | Zymeworks Inc. | Moore Paul Andrew | CSO | M - OptEx | $0.00 | +17.2K | 17.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations